| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
33,268 |
30,989 |
$2.63M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
19,426 |
17,260 |
$2.40M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
20,640 |
19,693 |
$1.80M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
10,327 |
9,422 |
$1.29M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,183 |
12,357 |
$1.14M |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
11,440 |
9,820 |
$1.04M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
10,053 |
9,038 |
$719K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,227 |
2,012 |
$570K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,852 |
3,657 |
$558K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,613 |
2,454 |
$420K |
| 80053 |
Comprehensive metabolic panel |
17,852 |
16,091 |
$405K |
| 36415 |
Collection of venous blood by venipuncture |
13,504 |
11,654 |
$388K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
6,632 |
2,511 |
$387K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,579 |
1,538 |
$382K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,528 |
3,478 |
$349K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,082 |
1,058 |
$299K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,983 |
2,890 |
$272K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,514 |
1,225 |
$237K |
| 81025 |
|
1,979 |
1,912 |
$213K |
| 87631 |
|
2,008 |
1,977 |
$209K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
6,705 |
6,349 |
$159K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,206 |
2,198 |
$126K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,330 |
4,737 |
$111K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,489 |
2,084 |
$104K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
443 |
437 |
$99K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,096 |
3,061 |
$92K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
821 |
817 |
$89K |
| 20610 |
|
575 |
441 |
$89K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
363 |
354 |
$86K |
| 97161 |
|
1,010 |
1,002 |
$84K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
843 |
841 |
$73K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,863 |
1,824 |
$68K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,771 |
1,478 |
$61K |
| 80061 |
Lipid panel |
6,512 |
6,457 |
$52K |
| 84443 |
Thyroid stimulating hormone (TSH) |
7,998 |
7,810 |
$51K |
| S5161 |
Emergency response system; service fee, per month (excludes installation and testing) |
1,457 |
1,448 |
$45K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
319 |
317 |
$44K |
| 87081 |
|
7,869 |
7,655 |
$43K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
328 |
327 |
$41K |
| 84484 |
|
2,676 |
1,664 |
$40K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
17,946 |
15,565 |
$36K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,826 |
1,789 |
$36K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
142 |
138 |
$32K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,315 |
4,273 |
$32K |
| 90686 |
|
794 |
789 |
$31K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
105 |
101 |
$30K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,509 |
1,504 |
$30K |
| 84439 |
|
4,251 |
4,180 |
$27K |
| 73130 |
|
1,079 |
1,016 |
$26K |
| 73110 |
|
806 |
737 |
$24K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,906 |
3,663 |
$23K |
| 51798 |
|
90 |
88 |
$22K |
| 73562 |
|
416 |
407 |
$20K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
2,741 |
2,506 |
$20K |
| 12001 |
|
40 |
40 |
$20K |
| 82607 |
|
1,803 |
1,792 |
$19K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,288 |
1,268 |
$19K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
491 |
481 |
$17K |
| 76830 |
Ultrasound, transvaginal |
538 |
535 |
$16K |
| 71046 |
Radiologic examination, chest; 2 views |
3,519 |
3,408 |
$16K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
138 |
138 |
$16K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,647 |
4,113 |
$16K |
| 71045 |
Radiologic examination, chest; single view |
2,275 |
2,164 |
$14K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
849 |
392 |
$14K |
| 11721 |
|
648 |
586 |
$14K |
| 82728 |
|
1,242 |
1,221 |
$14K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,222 |
1,861 |
$13K |
| 76770 |
|
112 |
111 |
$13K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,573 |
1,538 |
$13K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
106 |
106 |
$13K |
| 84703 |
|
1,902 |
1,820 |
$12K |
| 76642 |
|
259 |
256 |
$11K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
526 |
516 |
$10K |
| 86803 |
|
1,291 |
1,275 |
$10K |
| 86780 |
|
831 |
810 |
$10K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
211 |
161 |
$9K |
| 80076 |
|
1,150 |
1,134 |
$9K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
91 |
91 |
$9K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
295 |
293 |
$9K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
160 |
122 |
$8K |
| 83655 |
|
588 |
583 |
$8K |
| 85380 |
|
634 |
616 |
$8K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
89 |
61 |
$8K |
| 86900 |
|
421 |
403 |
$8K |
| 99201 |
|
97 |
97 |
$7K |
| 84702 |
|
768 |
561 |
$7K |
| 87340 |
|
750 |
737 |
$7K |
| 83540 |
|
1,671 |
1,639 |
$7K |
| 83735 |
|
3,031 |
2,575 |
$6K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,992 |
3,649 |
$6K |
| 85027 |
|
2,666 |
2,516 |
$6K |
| 85610 |
|
2,391 |
1,884 |
$6K |
| 73630 |
|
1,391 |
1,343 |
$5K |
| 76000 |
|
39 |
39 |
$5K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
149 |
67 |
$5K |
| 83880 |
|
151 |
145 |
$5K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
12 |
12 |
$5K |
| 76641 |
|
117 |
108 |
$4K |
| 86850 |
|
389 |
373 |
$4K |
| 73610 |
|
1,290 |
1,216 |
$4K |
| 81003 |
|
3,697 |
3,534 |
$4K |
| 86901 |
|
386 |
370 |
$4K |
| 99385 |
|
28 |
28 |
$4K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
24 |
24 |
$4K |
| 90715 |
|
146 |
146 |
$4K |
| 86618 |
|
313 |
309 |
$4K |
| 81001 |
|
3,187 |
2,980 |
$4K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
41 |
40 |
$4K |
| 77065 |
Tomosynthesis, mammo |
53 |
51 |
$3K |
| 99442 |
|
126 |
124 |
$3K |
| 87480 |
|
549 |
534 |
$3K |
| 83550 |
|
753 |
737 |
$3K |
| 82746 |
|
281 |
279 |
$3K |
| 86140 |
|
1,308 |
1,201 |
$3K |
| 84466 |
|
300 |
299 |
$3K |
| 84403 |
|
121 |
114 |
$3K |
| 72020 |
|
12 |
12 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,185 |
4,109 |
$3K |
| 93971 |
|
83 |
79 |
$3K |
| G0378 |
Hospital observation service, per hour |
99 |
80 |
$3K |
| 73030 |
|
697 |
684 |
$3K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
44 |
44 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
838 |
722 |
$3K |
| 86762 |
|
196 |
191 |
$3K |
| 85652 |
|
1,597 |
1,516 |
$2K |
| 87660 |
|
446 |
435 |
$2K |
| 86706 |
|
300 |
293 |
$2K |
| 87510 |
|
513 |
498 |
$2K |
| 82043 |
|
454 |
450 |
$2K |
| 82570 |
|
641 |
626 |
$2K |
| 87186 |
|
1,200 |
1,138 |
$2K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,026 |
1,953 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,129 |
2,734 |
$2K |
| 86704 |
|
235 |
228 |
$2K |
| 77066 |
Tomosynthesis, mammo |
25 |
25 |
$2K |
| 97165 |
|
25 |
25 |
$2K |
| 99215 |
Prolong outpt/office vis |
14 |
14 |
$2K |
| 83690 |
|
1,954 |
1,814 |
$2K |
| 11720 |
|
74 |
69 |
$1K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
50 |
50 |
$1K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
634 |
626 |
$1K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
53 |
52 |
$1K |
| 87070 |
|
355 |
344 |
$1K |
| 0012A |
|
38 |
38 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
31 |
29 |
$1K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
12 |
12 |
$1K |
| 76536 |
|
64 |
64 |
$1K |
| A9576 |
Injection, gadoteridol, (prohance multipack), per ml |
27 |
25 |
$1K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
12 |
12 |
$1K |
| 86038 |
|
210 |
209 |
$1K |
| 72100 |
|
145 |
144 |
$929.84 |
| 87420 |
|
382 |
372 |
$916.61 |
| 74018 |
|
260 |
248 |
$890.32 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,398 |
1,365 |
$823.50 |
| 73564 |
|
114 |
113 |
$720.56 |
| 84100 |
|
322 |
234 |
$697.51 |
| 83001 |
|
38 |
37 |
$666.92 |
| 73140 |
|
243 |
214 |
$661.24 |
| 87158 |
|
2,171 |
2,109 |
$651.88 |
| 86708 |
|
76 |
76 |
$643.04 |
| 99441 |
|
34 |
34 |
$573.75 |
| 73560 |
|
103 |
101 |
$528.65 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
50 |
50 |
$497.16 |
| 83605 |
|
916 |
854 |
$493.10 |
| 85730 |
|
334 |
320 |
$445.82 |
| 0011A |
|
31 |
31 |
$396.90 |
| 85007 |
|
433 |
389 |
$373.37 |
| 86617 |
|
17 |
17 |
$371.76 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
41 |
40 |
$350.85 |
| 72110 |
|
27 |
27 |
$346.04 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
13 |
13 |
$324.15 |
| 73502 |
|
103 |
100 |
$316.39 |
| 87040 |
|
589 |
374 |
$314.33 |
| 84146 |
|
17 |
16 |
$310.08 |
| 86430 |
|
64 |
64 |
$259.64 |
| 87205 |
|
265 |
250 |
$256.36 |
| 99443 |
|
15 |
15 |
$253.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,342 |
1,207 |
$236.63 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
308 |
292 |
$214.41 |
| 87400 |
|
512 |
497 |
$179.92 |
| 81002 |
|
165 |
160 |
$176.57 |
| 82150 |
|
155 |
153 |
$168.38 |
| 96376 |
|
699 |
510 |
$159.88 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
45 |
44 |
$141.10 |
| 73080 |
|
89 |
84 |
$116.51 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
49 |
49 |
$104.21 |
| 86364 |
|
13 |
12 |
$90.74 |
| 82247 |
|
68 |
64 |
$87.84 |
| 82550 |
|
42 |
41 |
$75.75 |
| 86308 |
|
25 |
25 |
$71.70 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
118 |
83 |
$66.87 |
| 84460 |
|
36 |
36 |
$60.45 |
| 73090 |
|
30 |
24 |
$60.00 |
| 82950 |
|
12 |
12 |
$57.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,145 |
1,953 |
$56.04 |
| 80179 |
|
278 |
258 |
$44.73 |
| 80143 |
|
310 |
287 |
$44.73 |
| 80306 |
|
84 |
81 |
$30.05 |
| 82805 |
|
28 |
25 |
$24.13 |
| 84155 |
|
37 |
37 |
$22.02 |
| 73590 |
|
12 |
12 |
$18.18 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,682 |
1,499 |
$15.17 |
| J2704 |
Injection, propofol, 10 mg |
787 |
766 |
$10.26 |
| 82040 |
|
25 |
25 |
$9.90 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
16 |
16 |
$8.48 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
307 |
305 |
$7.67 |
| 94760 |
|
155 |
136 |
$7.41 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
712 |
691 |
$7.30 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
207 |
185 |
$5.17 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
225 |
209 |
$3.34 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
121 |
96 |
$2.14 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
96 |
87 |
$1.17 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
13 |
12 |
$1.11 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
48 |
48 |
$0.50 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
173 |
139 |
$0.48 |
| 82077 |
|
77 |
75 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
89 |
87 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
190 |
149 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
64 |
51 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
315 |
302 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
12 |
12 |
$0.00 |
| 93000 |
|
27 |
27 |
$0.00 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
14 |
13 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
12 |
12 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
13 |
12 |
$0.00 |